Drugdiscovery >> Pharmaceutical Companies >> News
6665
Views
Pfizer- The world's largest research-based pharmaceutical company - drugdiscovery.com
Pfizer- The world's largest research-based pharmaceutical company - drugdiscovery.com


At Pfizer, science and global resources are applied in order to improve health and well-being at every stage of life.
Read More >>


Tags: pfizer, pharmaceutical company - July 15, 2013
Related Articles
4039
Views
The price of AstraZeneca 's stock increased after Pfizer's offer The price of AstraZeneca 's stock increased after Pfizer's offer
The price of AstraZeneca stocks runned up after Pfizer announced that it is willing to buy o buy the company for around $100 billion. Lately, AstraZeneca turned down another similar offer. Read More >>

Tags: Stock, pharmaceutival business, pharmaceutical companies, AstraZeneca,Pfizer, pharmaceutical stock exchange, pharma stocks, astrazeneca sold

4008
Views
AstraZeneca and Pfizer merger: Do cancer patients loose? AstraZeneca and Pfizer merger: Do cancer patients loose?
Even the most-sold drug of Pfizer was an aquisition. therefore, expert predict that the company can only survive if it merges with others. Read More >>

Tags: pfizer, astrazeneca, pfizer merge, astra zeneca aquisition

4840
Views
What is happening with AstraZeneca. What is happening with AstraZeneca.
Pfizer announced to buy AstraZeneca many times. But what is in the backround of this diecision and what is happening with the two companies? Read More >>

Tags: Astra Zeneca, Pfizer, pharmaceutical companies, astraZeneca business.

3546
Views
The top respected pharma brand in the US The top respected pharma brand in the US
According to the latest "BrandPower Ranking" Bayer, a german chemical and pharmaceutical company, was ranked fifth among the 100 best-known and most popular brands in the US, but first among pharmaceu Read More >>

Tags: Bayer, ranking, top, respected, pharmaceutical company, most popular, brand

4062
Views
AstraZeneca links with privately held company to research cancer AstraZeneca links with privately held company to research cancer
AstraZeneca has announced that its biologic development arm is going to co-operate with Immunocore Limited. This is a privately held company and works on T-cell related researches. Read More >>

Tags: T-cell, AstraZeneca, Immunocore, co-operation

1599
Views
Pharmaceutical companies team up to deal with Pharmaceutical companies team up to deal with "big data challenge"
Cancer Research UK says it teams up with other oharmaceutical and technical companies to solve the big data problems. huge amounts of DATA received from studies is going to be analyzed now. Read More >>

Tags: DATA, analisys, study, big data, cancer research, big data cancer research, Cancer research UK

2531
Views
Lilly Paharmaceuticals az Pfizer share the cost of major researches. Lilly Paharmaceuticals az Pfizer share the cost of major researches.
Tanezumab is a pain-reliever being developed by Lilly pharmaceuticals. The company announced that it has signed a 1,8 billion dollar agreement with Pfizer to help the development. Read More >>

Tags: tanezumab, Lilly, research, contirbution.

4270
Views
A collaboration between Sanford-Burnham and Pfizer A collaboration between Sanford-Burnham and Pfizer
Sanford-Burnham Medical Research Institute (Sanford-Burnham) has entered into a collaboration with Pfizer Inc. with the aim of identifying new therapeutic targets and strategies for preventing and tre Read More >>

Tags: Sanford-Burnham, Pfizer, colaboration, insulin resistance

3758
Views
GlaxoSmithKline and Novartis sigent a three-part agreemnet GlaxoSmithKline and Novartis sigent a three-part agreemnet
GSK will accquire vaccines of Novartis. This is only one point of the three-part agreement which was signed by the two pharmaceutical giants. Both companies hope development. Read More >>

Tags: novartis, GKS, vaccination business, pharmaceutical business, pharmaceutical news, pharmaceutical business news.

2130
Views
Novartis contributes with GSK and changes protfolio Novartis contributes with GSK and changes protfolio
Novartis announced that it is going to transform its portfolio and strenghtens its researches by acquiring products of GSK's oncology wing. Read More >>

Tags: GSK, Novartis, pharmaceutical companies, pharmaceutical news, drug discovery, oncology srugs

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013